P-621 Concurrent hyperfractionated radiotherapy (Hfx RT) and low-dosedaily carboplatin/paclitaxel (C/P) in patients with early stage (I/II) non-small cell lung cancer (NSCLC). Long-term results of a phase II study
Jeremic, B., Milicic, B., Radosavljevic-Asic, G.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81114-6
Date:
July, 2005
File:
PDF, 124 KB
english, 2005